TrialEuropean heart journal2015

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.

Eugene S Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.